Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs. read more
Gunnar F. Kaufmann ā Senior VP of Immunotherapy and Head of Research & Global Partnerships at Sorrento Therapeutics
Executive Bio
Dr. Gunnar F. Kaufmann has been Senior Vice President of Immunotherapy and Head of Research & Global Partnerships at Sorrento Therapeutics, Inc. since September 14, 2017. Dr. Kaufmann serves as the Chairperson of NIH study sections. Dr. Kaufmann holds an adjunct faculty position at TSRI. He has co-authored 50 peer-reviewed publications. He served as faculty at The Scripps Research Institute (TSRI) studying antibody and vaccine immunotherapies as well as the interplay between pathogens and host innate immunity. Dr. Kaufmann obtained his M.S. in Human Biology from University of Greifswald (Germany) and his Ph.D. in Macromolecular and Cellular Structure and Chemistry from The Scripps Research Institute, La Jolla.
Executive Team Culture Ratings from Sorrento Therapeutics Employees
BOTTOM
45%
Sorrento Therapeutics' Executive Team scores in the Bottom 45%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Sorrento TherapeuticsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Sorrento TherapeuticsSorrento Therapeutics' Executive Team at a Glance
Based on 9 ratings, Sorrento Therapeutics' employees are less satisfied with their Executive Team and give them a āCā or 69/100.
Sorrento Therapeutics' Executive Team ranks in the Top 50% of other companies in San Diego and Bottom 45% of other companies on Comparably that also have 51-200 Employees.
×